WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report)’s stock price traded down 1.1% during mid-day trading on Wednesday . The company traded as low as $15.38 and last traded at $15.40. 2,627 shares were traded during mid-day trading, The stock had previously closed at $15.58.
WisdomTree BioRevolution Fund Stock Performance
The business has a 50 day moving average price of $16.84 and a 200-day moving average price of $15.93. The company has a market capitalization of $2.31 million, a price-to-earnings ratio of 16.52 and a beta of 1.18.
Hedge Funds Weigh In On WisdomTree BioRevolution Fund
A hedge fund recently raised its stake in WisdomTree BioRevolution Fund stock. Flow Traders U.S. LLC increased its holdings in WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 15.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 93,700 shares of the company’s stock after acquiring an additional 12,679 shares during the period. Flow Traders U.S. LLC’s holdings in WisdomTree BioRevolution Fund were worth $1,627,000 at the end of the most recent quarter.
About WisdomTree BioRevolution Fund
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Further Reading
- Five stocks we like better than WisdomTree BioRevolution Fund
- Manufacturing Stocks Investing
- United Airlines Soars on Earnings Beat
- EV Stocks and How to Profit from Them
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.
